163 related articles for article (PubMed ID: 20487594)
1. An audit of the role of vitamin K in the reversal of International Normalised Ratio (INR) in patients undergoing surgery for hip fracture.
Bhatia M; Talawadekar G; Parihar S; Smith A
Ann R Coll Surg Engl; 2010 Sep; 92(6):473-6. PubMed ID: 20487594
[TBL] [Abstract][Full Text] [Related]
2. Comparison of different warfarin reversal protocols on surgical delay and complication rate in hip fracture patients.
Leonidou A; Rallan R; Cox N; Pagkalos J; Luscombe J
J Orthop Surg (Hong Kong); 2013 Aug; 21(2):142-5. PubMed ID: 24014771
[TBL] [Abstract][Full Text] [Related]
3. Preoperative warfarin reversal for early hip fracture surgery.
Moores TS; Beaven A; Cattell AE; Baker C; Roberts PJ
J Orthop Surg (Hong Kong); 2015 Apr; 23(1):33-6. PubMed ID: 25920640
[TBL] [Abstract][Full Text] [Related]
4. Reversal of asymptomatic over-anticoagulation by orally administered vitamin K.
Baker P; Gleghorn A; Tripp T; Paddon K; Eagleton H; Keeling D
Br J Haematol; 2006 May; 133(3):331-6. PubMed ID: 16643436
[TBL] [Abstract][Full Text] [Related]
5. Vitamin K dosing to reverse warfarin based on INR, route of administration, and home warfarin dose in the acute/critical care setting.
Tsu LV; Dienes JE; Dager WE
Ann Pharmacother; 2012 Dec; 46(12):1617-26. PubMed ID: 23249867
[TBL] [Abstract][Full Text] [Related]
6. Treatment with vitamin K in hip fracture patients receiving warfarin.
Tal A; Rubin G; Rozen N
Isr Med Assoc J; 2013 Jul; 15(7):348-51. PubMed ID: 23943978
[TBL] [Abstract][Full Text] [Related]
7. Anticoagulation management in hip fracture patients on warfarin.
Al-Rashid M; Parker MJ
Injury; 2005 Nov; 36(11):1311-5. PubMed ID: 16214475
[TBL] [Abstract][Full Text] [Related]
8. Association of Reversal of Anticoagulation Preoperatively on 30-Day Mortality and Outcomes for Hip Fracture Surgery.
Yoo MS; Zhu S; Jiang SF; Hammer HL; McBride WJ; McCarthy CM; Green CE; Ananias MP
Am J Med; 2020 Aug; 133(8):969-975.e2. PubMed ID: 32007455
[TBL] [Abstract][Full Text] [Related]
9. Reversal of overanticoagulation in very elderly hospitalized patients with an INR above 5.0: 24-hour INR response after vitamin K administration.
Pautas E; Peyron I; Bouhadiba S; Golmard JL; Gouronnec A; Oboa N; Siguret V; Gouin-Thibault I
Am J Med; 2011 Jun; 124(6):527-33. PubMed ID: 21605730
[TBL] [Abstract][Full Text] [Related]
10. Vitamin K for improved anticoagulation control in patients receiving warfarin.
Mahtani KR; Heneghan CJ; Nunan D; Roberts NW
Cochrane Database Syst Rev; 2014 May; (5):CD009917. PubMed ID: 24832594
[TBL] [Abstract][Full Text] [Related]
11. Assessment of the efficacy of a novel tailored vitamin K dosing regimen in lowering the International Normalised Ratio in over-anticoagulated patients: a randomised clinical trial.
Kampouraki E; Avery PJ; Wynne H; Biss T; Hanley J; Talks K; Kamali F
Br J Haematol; 2017 Sep; 178(5):800-809. PubMed ID: 28771671
[TBL] [Abstract][Full Text] [Related]
12. Optimal dose of prothrombin complex concentrate for acute reversal of oral anticoagulation.
Yasaka M; Sakata T; Naritomi H; Minematsu K
Thromb Res; 2005; 115(6):455-9. PubMed ID: 15792675
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of warfarin reversal in orthopedic trauma surgery patients.
Tharmarajah P; Pusey J; Keeling D; Willett K
J Orthop Trauma; 2007 Jan; 21(1):26-30. PubMed ID: 17211265
[TBL] [Abstract][Full Text] [Related]
14. Results of Octaplex for reversal of warfarin anticoagulation in patients with hip fracture.
Ng R; Shabani-Rad MT
Can J Surg; 2019 Feb; 62(1):14-19. PubMed ID: 30265643
[TBL] [Abstract][Full Text] [Related]
15. Low-dose oral vitamin K to normalize the international normalized ratio prior to surgery in patients who require temporary interruption of warfarin.
Woods K; Douketis JD; Kathirgamanathan K; Yi Q; Crowther MA
J Thromb Thrombolysis; 2007 Oct; 24(2):93-7. PubMed ID: 17380255
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of warfarin management with international normalized ratio self-testing and online remote monitoring and management plus low-dose vitamin k with genomic considerations: a pilot study.
Bussey HI; Bussey M; Bussey-Smith KL; Frei CR
Pharmacotherapy; 2013 Nov; 33(11):1136-46. PubMed ID: 24038412
[TBL] [Abstract][Full Text] [Related]
17. Effects of oral vitamin K on S- and R-warfarin pharmacokinetics and pharmacodynamics: enhanced safety of warfarin as a CYP2C9 probe.
Kim JS; Nafziger AN; Gaedigk A; Dickmann LJ; Rettie AE; Bertino JS
J Clin Pharmacol; 2001 Jul; 41(7):715-22. PubMed ID: 11452703
[TBL] [Abstract][Full Text] [Related]
18. The use of vitamin K in patients on anticoagulant therapy: a practical guide.
Hanslik T; Prinseau J
Am J Cardiovasc Drugs; 2004; 4(1):43-55. PubMed ID: 14967065
[TBL] [Abstract][Full Text] [Related]
19. Short-term warfarin reversal for elective surgery--using low-dose intravenous vitamin K: safe, reliable and convenient*.
Burbury KL; Milner A; Snooks B; Jupe D; Westerman DA
Br J Haematol; 2011 Sep; 154(5):626-34. PubMed ID: 21751986
[TBL] [Abstract][Full Text] [Related]
20. Effectiveness and safety of a management protocol to correct over-anticoagulation with oral vitamin K: a retrospective study of 1,043 cases.
Denas G; Marzot F; Offelli P; Stendardo A; Cucchini U; Russo R; Nante G; Iliceto S; Pengo V
J Thromb Thrombolysis; 2009 Apr; 27(3):340-7. PubMed ID: 18338109
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
